Related Experiment Video
Updated: Jul 13, 2026

06:41
Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
Published on: July 19, 2024
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential
Silvia Deaglio1, Tiziana Vaisitti, Semra Aydin
1Department of Genetics, Biology and Biochemistry, University of Torino Medical School, Turin, Italy. silvia.deaglio@unito.it
Blood
|August 19, 2007
Summary
Chronic lymphocytic leukemia (CLL) CD38 and ZAP-70 markers predict aggressive disease. Their combined analysis in patients enhances identification of aggressive CLL, aiding clinical trial stratification.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Background:
- CD38 plays a role in chronic lymphocytic leukemia (CLL) pathogenesis.
- CD38 signaling is modulated by interactions with CD31 ligand on nurse-like cells and stromal/endothelial components.
- Understanding CD38's in vivo function is crucial for CLL patient stratification.
Purpose of the Study:
- To investigate the functional link between CD38 and ZAP-70 in CLL.
- To determine if CD38 and ZAP-70 expression can predict disease aggressiveness.
- To identify genetic signatures associated with migratory potential in CLL.
Main Methods:
- Analysis of a cohort of 56 clinically and molecularly characterized CLL patients.
- Assessment of CD38 and ZAP-70 expression and their correlation with migration.
- Study of CD38-mediated signal transduction and ZAP-70's role in 26 patients.
- Gene expression profiling to identify genetic signatures related to cell migration.
Main Results:
- CD38 positive/ZAP-70 positive CLL patients exhibit increased migration towards Stromal Derived Factor-1alpha (SDF-1alpha)/CXCL12.
- CD38 ligation induces tyrosine phosphorylation of ZAP-70, indicating a functional link.
- ZAP-70 acts as a limiting factor in the CD38 pathway within the CLL context.
- A distinct genetic signature, involving cell-cell interactions and movement genes, characterizes CLL subgroups with specific migratory potential.
Conclusions:
- Combined analysis of CD38 and ZAP-70 expression reliably identifies aggressive CLL.
- These markers provide a more dependable method for patient identification in clinical trials.
- The findings offer biological evidence supporting the use of CD38 and ZAP-70 in CLL prognostication.
